vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.
First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $20.0M, roughly 1.3× AGIOS PHARMACEUTICALS, INC.). First Bancorp, Inc runs the higher net margin — 39.4% vs -541.1%, a 580.4% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 17.5%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 18.1%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
AGIO vs FNLC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $25.8M |
| Net Profit | $-108.0M | $10.2M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 48.1% |
| Net Margin | -541.1% | 39.4% |
| Revenue YoY | 86.1% | 17.5% |
| Net Profit YoY | -11.9% | 39.7% |
| EPS (diluted) | $-1.86 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $25.8M | ||
| Q3 25 | $12.9M | $24.5M | ||
| Q2 25 | $12.5M | $22.5M | ||
| Q1 25 | $8.7M | $21.8M | ||
| Q4 24 | $10.7M | $22.0M | ||
| Q3 24 | $9.0M | $20.5M | ||
| Q2 24 | $8.6M | $19.2M | ||
| Q1 24 | $8.2M | $18.5M |
| Q4 25 | $-108.0M | $10.2M | ||
| Q3 25 | $-103.4M | $9.1M | ||
| Q2 25 | $-112.0M | $8.1M | ||
| Q1 25 | $-89.3M | $7.1M | ||
| Q4 24 | $-96.5M | $7.3M | ||
| Q3 24 | $947.9M | $7.6M | ||
| Q2 24 | $-96.1M | $6.2M | ||
| Q1 24 | $-81.5M | $6.0M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | 48.1% | ||
| Q3 25 | -907.4% | 45.2% | ||
| Q2 25 | -1020.1% | 43.7% | ||
| Q1 25 | -1222.0% | 39.3% | ||
| Q4 24 | -1165.3% | 39.5% | ||
| Q3 24 | -1146.9% | 44.6% | ||
| Q2 24 | -1228.3% | 38.8% | ||
| Q1 24 | -1124.3% | 39.3% |
| Q4 25 | -541.1% | 39.4% | ||
| Q3 25 | -803.1% | 37.0% | ||
| Q2 25 | -899.4% | 35.8% | ||
| Q1 25 | -1023.3% | 32.5% | ||
| Q4 24 | -899.6% | 33.1% | ||
| Q3 24 | 10574.7% | 36.9% | ||
| Q2 24 | -1115.7% | 32.1% | ||
| Q1 24 | -995.8% | 32.5% |
| Q4 25 | $-1.86 | $0.91 | ||
| Q3 25 | $-1.78 | $0.81 | ||
| Q2 25 | $-1.93 | $0.72 | ||
| Q1 25 | $-1.55 | $0.63 | ||
| Q4 24 | $-1.44 | $0.66 | ||
| Q3 24 | $16.22 | $0.68 | ||
| Q2 24 | $-1.69 | $0.55 | ||
| Q1 24 | $-1.45 | $0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | $95.5M |
| Stockholders' EquityBook value | $1.2B | $283.1M |
| Total Assets | $1.3B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | — | ||
| Q2 25 | $80.9M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | — | ||
| Q1 24 | $118.8M | — |
| Q4 25 | — | $95.5M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | $95.0M | ||
| Q3 24 | — | $95.0M | ||
| Q2 24 | — | $70.0M | ||
| Q1 24 | — | $70.0M |
| Q4 25 | $1.2B | $283.1M | ||
| Q3 25 | $1.3B | $274.6M | ||
| Q2 25 | $1.4B | $265.5M | ||
| Q1 25 | $1.5B | $259.7M | ||
| Q4 24 | $1.5B | $252.5M | ||
| Q3 24 | $1.6B | $256.8M | ||
| Q2 24 | $660.5M | $244.7M | ||
| Q1 24 | $743.9M | $242.6M |
| Q4 25 | $1.3B | $3.2B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.5B | $3.2B | ||
| Q1 25 | $1.6B | $3.2B | ||
| Q4 24 | $1.7B | $3.2B | ||
| Q3 24 | $1.8B | $3.1B | ||
| Q2 24 | $773.1M | $3.1B | ||
| Q1 24 | $849.7M | $3.0B |
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.29× | ||
| Q1 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $37.8M |
| Free Cash FlowOCF − Capex | $-97.3M | $34.6M |
| FCF MarginFCF / Revenue | -487.5% | 133.9% |
| Capex IntensityCapex / Revenue | 5.6% | 12.5% |
| Cash ConversionOCF / Net Profit | — | 3.72× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $37.8M | ||
| Q3 25 | $-88.2M | $12.9M | ||
| Q2 25 | $-77.1M | $7.4M | ||
| Q1 25 | $-111.5M | $2.2M | ||
| Q4 24 | $-133.2M | $26.0M | ||
| Q3 24 | $-84.2M | $9.8M | ||
| Q2 24 | $-72.6M | $6.4M | ||
| Q1 24 | $-99.9M | $-1.5M |
| Q4 25 | $-97.3M | $34.6M | ||
| Q3 25 | $-89.7M | $12.6M | ||
| Q2 25 | $-78.0M | $7.2M | ||
| Q1 25 | $-112.3M | $828.0K | ||
| Q4 24 | $-134.1M | $24.6M | ||
| Q3 24 | $-84.6M | $9.6M | ||
| Q2 24 | $-72.7M | $6.3M | ||
| Q1 24 | $-100.0M | $-1.8M |
| Q4 25 | -487.5% | 133.9% | ||
| Q3 25 | -696.5% | 51.4% | ||
| Q2 25 | -626.2% | 32.1% | ||
| Q1 25 | -1286.4% | 3.8% | ||
| Q4 24 | -1250.1% | 111.7% | ||
| Q3 24 | -944.2% | 47.0% | ||
| Q2 24 | -844.4% | 32.9% | ||
| Q1 24 | -1221.2% | -9.8% |
| Q4 25 | 5.6% | 12.5% | ||
| Q3 25 | 12.1% | 1.2% | ||
| Q2 25 | 7.0% | 0.6% | ||
| Q1 25 | 8.8% | 6.2% | ||
| Q4 24 | 9.0% | 6.7% | ||
| Q3 24 | 4.7% | 0.5% | ||
| Q2 24 | 1.8% | 0.3% | ||
| Q1 24 | 1.7% | 1.8% |
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 1.42× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | -0.09× | 1.29× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | -0.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
